COMP <GO>
ULBI vs RTX // EV/EBITDA & P/E VALUATION
Ultralife Corporation (NASDAQ) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: ULBI 2
— RTX 8
■ METRIC PARITY
LAST: $15.62 (+0.06%) • MKT CAP: $260.3M
valuation
—
LAST: $199.40 (+1.82%) • MKT CAP: $269.08B
valuation
26.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULBI VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULBI | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.80% | 7.20% | -10.00 | RTX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 26.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.73% | 2.95% | -0.22 | RTX | /fcf-yield <GO> |
| Operating Margin | -3.10% | 10.50% | -13.60 | RTX | /operating-margins <GO> |
| Net Profit Margin | -3.10% | 7.60% | -10.70 | RTX | /net-margins <GO> |
| Revenue Growth (YoY) | 16.20% | 9.70% | +6.50 | ULBI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.33% | -1.33 | RTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.71 | 2.73 | -0.02 | RTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | RTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 93.4 | 60.0 | +33.43 | ULBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 37.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $260.3M | $269.08B | -$268.82B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULBI REV | RTX REV | ULBI GROSS % | RTX GROSS % | ULBI FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $191.2M | $88.60B | 24.1% | — | $7.1M | $7.94B |
| FY 2024 | $164.5M | $80.74B | 25.7% | — | $14.7M | $4.53B |
| FY 2023 | $158.6M | $68.92B | — | — | $1.9M | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULBI // BETA —
RTX // BETA 0.92